These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8119976)

  • 1. Caged nitric oxide. Stable organic molecules from which nitric oxide can be photoreleased.
    Makings LR; Tsien RY
    J Biol Chem; 1994 Mar; 269(9):6282-5. PubMed ID: 8119976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nitric oxide on agonist-mediated calcium mobilization in platelets.
    Rao GH; Krishnamurthi S; Raij L; White JG
    Biochem Med Metab Biol; 1990 Jun; 43(3):271-5. PubMed ID: 2383431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
    Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
    Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
    Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
    Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
    Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
    Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release.
    Hogaboam CM; Befus AD; Wallace JL
    J Immunol; 1993 Oct; 151(7):3767-74. PubMed ID: 8397260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet activation by carbon monoxide: comparison with nitric oxide.
    Naseem KM; Bruckdorfer KR
    Biochem Soc Trans; 1997 Aug; 25(3):396S. PubMed ID: 9388626
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW; Mackie IJ; Machin SJ
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
    Amano M; Takahashi M; Kosaka T; Kinoshita M
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):860-6. PubMed ID: 7898066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide derived from endothelial cells inhibits Na+/H+ exchange in rabbit platelets activated by thrombin.
    Chen H; Guo ZG
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):333-7. PubMed ID: 10452119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid.
    Lechi C; Gaino S; Tommasoli R; Zuliani V; Bonapace S; Fontana L; Degan M; Lechi A; Minuz P
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):206-9. PubMed ID: 8735820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
    Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
    Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct electrochemical measurement of nitric oxide released from human platelets.
    Malinski T; Radomski MW; Taha Z; Moncada S
    Biochem Biophys Res Commun; 1993 Jul; 194(2):960-5. PubMed ID: 8343175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of thrombin-induced platelet aggregation by the novel nitric oxide-donor GEA 3175 and adenosine.
    Grenegård M; Gustafsson MC; Andersson RG; Bengtsson T
    Br J Pharmacol; 1996 Aug; 118(8):2140-4. PubMed ID: 8864553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF).
    Barrett ML; Willis AL; Vane JR
    Agents Actions; 1989 Jun; 27(3-4):488-91. PubMed ID: 2508448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid reversibility of nitric oxide induced platelet inhibition.
    Brüne B; Hanstein K
    Thromb Res; 1998 Apr; 90(2):83-91. PubMed ID: 9684761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.